Tarshis J, Zuckerman J E, Katz N P, Segal S, Mushlin P S
Department of Anesthesia, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Can J Anaesth. 1997 Dec;44(12):1278-81. doi: 10.1007/BF03012776.
We report the peripartum anaesthetic management for vaginal delivery of a chronic pain patient with an implanted intrathecal pump. This is the first report describing labour analgesia in a patient with such a device. As intrathecal systems become more popular for the management of nonmalignant pain, this situation is likely to be encountered with increasing frequency in the future.
The patient was a nulliparous 23-yr-old with a history of chronic hereditary pancreatitis whose intractable pain had been managed with intrathecal morphine 3 mg.day-1 via an implantable pump for four years. Inadequate time between presentation and onset of labour prevented us from using this system. Intravenous patient controlled analgesia with fentanyl using a bolus of 25 micrograms and a lockout of five minutes was ineffective and epidural analgesia using bupivacaine was initiated and resulted in satisfactory analgesia.
The presence of an existing intrathecal delivery system does not preclude the use of supplemental epidural analgesia during labour.
我们报告了一名植入鞘内泵的慢性疼痛患者经阴道分娩时的围产期麻醉管理情况。这是首篇描述此类装置患者分娩镇痛的报告。随着鞘内给药系统在非恶性疼痛管理中越来越普遍,未来这种情况可能会更频繁地出现。
该患者为23岁初产妇,有慢性遗传性胰腺炎病史,其顽固性疼痛通过植入式泵鞘内注射吗啡3毫克/天进行治疗,已持续四年。就诊至分娩开始间隔时间不足,使我们无法使用该系统。静脉自控镇痛使用芬太尼,单次剂量25微克,锁定时间5分钟,效果不佳,遂开始使用布比卡因进行硬膜外镇痛,结果镇痛效果满意。
已有的鞘内给药系统并不妨碍在分娩期间使用补充性硬膜外镇痛。